William Durant
Ophthalmology · Reno, NVNPI 1669441309
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.7% of the total across 91 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by Novartis at 33.4% of the total. Reporting peaked in 2019 at $1,816 and has fallen 98.6% since, to $25 in 2025.
Across 91 payments — averaging $39.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$1K
- AbbVie$575
- Genentech USA, Inc.$518
- Aerie Pharmaceuticals, Inc.$246
- Ocular Therapeutix, Inc.$151
- Astellas Pharma US Inc$149
- plus $766 from 17 others
What the payments were for
- Travel & lodging$1915%
- Food & beverage$3,41795%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 30 | $1,203 |
| AbbVie(2 entities) | 20 | $575 |
| Genentech USA, Inc. | 7 | $518 |
| Aerie Pharmaceuticals, Inc. | 8 | $246 |
| Ocular Therapeutix, Inc. | 2 | $151 |
| Astellas Pharma US Inc | 2 | $149 |
| Oyster Point Pharma, Inc. | 1 | $134 |
| Genentech, Inc. | 1 | $105 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $99 |
| Biogen | 1 | $97 |
| Regeneron Healthcare Solutions, Inc. | 3 | $54 |
| Biotissue Holdings Inc. | 2 | $41 |
| Alimera Sciences, Inc. | 2 | $35 |
| Optos, Inc. | 1 | $26 |
| ANI Pharmaceuticals, Inc. | 1 | $25 |
| Sun Pharmaceutical Industries Inc. | 1 | $24 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $22 |
| Vyera Pharmaceuticals, LLC | 1 | $21 |
| Kala Pharmaceuticals, Inc. | 1 | $18 |
| Notal Vision, Inc. | 1 | $18 |
| Eyepoint US, Inc. | 1 | $17 |
| Amgen | 1 | $15 |
| Alcon | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,608 in reported general payments places this provider in the 70th percentile of 121 ophthalmology providers in Nevada.
Other ophthalmology in Reno
- Arshad KhananiReno$2M
- Steve ChangReno$75K
- Matthew MillsReno$15K
- Elena GeraymovychReno$14K
- Jamison EngleReno$6K
- Kevin GamettReno$6K
- Caleb MorrisReno$4K
- Hardeep DhindsaReno$3K
- Peter FreemanReno$3K
- Xintong LiReno$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.